BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
BioAtla, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.31−0.05 (-3.68%)
Close on Oct 19, 2026
- Market cap
- $2.18M
- P/E (TTM)
- –
- Dividend yield
- –
BioAtla statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | BioAtla | Industry median |
|---|---|---|
| Market Cap | $2.18M | $197.05M |
| Enterprise Value | $638.59K | $106.56M |
Income (trailing twelve months)
| Measure | BioAtla | Industry median |
|---|---|---|
| Operating Income | -$32.13M | -$21.44M |
| Net Income | -$31.45M | -$22.46M |
| EBITDA | -$31.93M | -$16.91M |
| EPS (Diluted) | -$25.63 | -$0.83 |
Returns
| Measure | BioAtla | Industry median |
|---|---|---|
| Return on Assets (ROA) | -171.7% | -41.0% |
Balance sheet
| Measure | BioAtla | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.54M | $62.42M |
| Net Cash (Debt) | $1.54M | $15.68M |
| Net Cash Per Share | $0.93 | $0.65 |
| Equity (Book Value) | -$36.24M | $48.79M |
| Book Value Per Share | -$21.75 | $1.36 |
| Tangible Book Value | -$36.24M | $23.06M |
| Working Capital | -$16.76M | $75.77M |
Financial position
| Measure | BioAtla | Industry median |
|---|---|---|
| Current Ratio | 0.20 | 3.30 |
| Quick Ratio | 0.17 | 2.39 |
Cash flow (trailing twelve months)
| Measure | BioAtla | Industry median |
|---|---|---|
| Operating Cash Flow | -$23.48M | -$12.35M |
Efficiency
| Measure | BioAtla | Industry median |
|---|---|---|
| Profits Per Employee | -$767.17K | -$732.08K |
| Employee Count | 41 | 73 |
Dividends and yields
| Measure | BioAtla | Industry median |
|---|---|---|
| Earnings Yield | -1441.1% | -21.2% |
Shares
| Measure | BioAtla | Industry median |
|---|---|---|
| Shares Outstanding | 1,666,100 | 59,128,900 |
| Shares Change (YoY) | 28.9% | 11.1% |
| Shares Change (QoQ) | 0.22% | 0.54% |
| Shares Held by Institutions | 11.2% | 59.4% |
Scores
| Measure | BioAtla | Industry median |
|---|---|---|
| Altman Z-Score | -94.47 | 0.10 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from BioAtla's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.